Literature DB >> 21908502

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F Eckel1, T Brunner, S Jelic.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908502     DOI： 10.1093/annonc/mdr375

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  30 in total

Review 1.  Systemic Therapy of Cholangiocarcinoma.

Authors:  Ruben R Plentz; Nisar P Malek
Journal:  Visc Med       Date:  2016-11-30

Review 2.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

Review 3.  Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era.

Authors:  Megan R D'Andrea; Corey M Gill; Melissa Umphlett; Nadejda M Tsankova; Mary Fowkes; Joshua B Bederson; Priscilla K Brastianos; Raj K Shrivastava
Journal:  Oncologist       Date:  2019-11-06

Review 4.  Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience.

Authors:  Marco Massani; Cristina Nistri; Cesare Ruffolo; Roberta Bonariol; Bruno Pauletti; Luca Bonariol; Ezio Caratozzolo; Giovanni Morana; Nicolò Bassi
Journal:  Updates Surg       Date:  2015-12

Review 5.  Positioning high-dose radiation in multidisciplinary management of unresectable cholangiocarcinomas: review of current evidence.

Authors:  Supriya Chopra; Ashwathy S Mathew; Reena Engineer; Shyam K Shrivastava
Journal:  Indian J Gastroenterol       Date:  2014-08-20

6.  Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma.

Authors:  A Salman; E Simoneau; M Hassanain; P Chaudhury; L M Boucher; D Valenti; T Cabrera; C Nudo; P Metrakos
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

7.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

8.  Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma.

Authors:  Matthias Unseld; Werner Scheithauer; Roman Weigl; Gabriela Kornek; Nadja Stranzl; Daniela Bianconi; Georg Brunauer; Guenther Steger; Christoph C Zielinski; Gerald W Prager
Journal:  J Gastrointest Oncol       Date:  2016-08

9.  Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.

Authors:  M Sinn; A Nicolaou; B Gebauer; P Podrabsky; D Seehofer; J Ricke; B Dörken; H Riess; B Hildebrandt
Journal:  Dig Dis Sci       Date:  2013-03-24       Impact factor: 3.199

10.  Chemotherapy Compared with Best Supportive Care for Metastatic/Unresectable Gallbladder Cancer: a Non-randomized Prospective Cohort Study.

Authors:  Santosh Kumar Singh; Rajnish Talwar; Narayanan Kannan; Arvind Kumar Tyagi; Pradeep Jaiswal; Adarsh Kumar
Journal:  Indian J Surg Oncol       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.